|
|
|
|
 |
|||
|
|||
Originally published as JHC exPRESS on January 22, 2007.
doi:10.1369/jhc.6A7110.2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Volume 55 (5): 487-493, 2007
Copyright ©The Histochemical Society, Inc.
Granulogenesis in Non-neuroendocrine COS-7 Cells Induced by EGFP-tagged Chromogranin A Gene Transfection: Identical and Distinct Distribution of CgA and EGFP
Department of Pathology (CI,SU,NE,TM,ST,RYO) and Teaching and Research Support Center (YI,JI), Tokai University School of Medicine, Kanagawa, Japan; Department of Medicine (LT) and Department of Pharmacology, Center for Human Genetics and Genomics (DTO), University of California–San Diego, La Jolla, California; and Veterans Affairs, San Diego Healthcare System, San Diego, California (DTO)
Correspondence to: Chie Inomoto, Dept. of Pathology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan. E-mail: cisophia{at}is.icc.u-tokai.ac.jp
 |
Summary |
|---|
 Top Summary IntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
We examined whether an enhanced green fluorescent protein (EGFP)-tagged chromogranin A (CgA) gene construct could serve as a marker protein to follow the synthesis of CgA and the process of granulogenesis in non-neuroendocrine (NE) cells. We transfected a CgA-EGFP expression vector into non-NE COS-7 cells and investigated the localization of a chimeric CgA-EGFP protein using confocal laser scanning microscopy (CLSM). The fluorescent signal of CgA-EGFP was distributed granularly in the cytoplasm. An immunocytochemical study using anti-CgA antibody with a quantum dot (Qd)525 shows colocalization of fluorescent signal of chimeric CgA-EGFP and CgA-Qd525 signals in granular structures, particularly at the periphery of the cytoplasm. We interpreted granules that were immunoreactive to CgA in electron micrographs as secretory. Spectral analysis of EGFP fluorescence revealed distinct EGFP signals without CgA colocalization. This is the first report to show that a granular structure can be induced by transfecting the EGFP-tagged human CgA gene into non-NE cells. The EGFP-tagged CgA gene could be a useful tool to investigate processes of the regulatory pathway. A more precise analysis of the fluorescence signal of EGFP by combination with the Qd system or by spectral analysis with CLSM can provide insight into biological phenomena. (J Histochem Cytochem 55:487–493, 2007)
Key Words: chromogranin A • enhanced green fluorescent protein • granulogenesis • COS-7 • confocal laser scanning microscopy
|
Introduction |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
NEUROENDOCRINE (NE) cells possess a regulated secretory pathway in addition to the constitutive secretory pathway that is present in all cells (Winkler and Fischer-Colbrie 1992
). Bioactive molecules such as neuropeptides are released from specialized NE cells through the regulated secretory pathway in which secretory granules (SGs) comprise specialized organelles. Immature SGs (ISGs) formed in the trans-Golgi network (TGN) (Arvan and Castle 1998; Tooze 1998) convert to mature SGs (MSGs), increase in size, and then modify the membrane composition and content of NE cells. Proteins entering the regulated pathway are concentrated and stored in SGs and subsequently released by exocytosis upon stimulation by secretagogues. In contrast, protein synthesized de novo in the constitutive secretory pathway is not stored but leaves the Golgi complex in transient membrane vesicles that immediately fuse with the plasma membrane, even in the absence of extracellular signaling.
The accepted model of SG biogenesis comprises four distinct steps ultimately leading to the formation of MSGs. These are (1) aggregation of the regulated secretory protein (RSP) and its sorting to the membrane in the TGN, (2) budding from the TGN, (3) homotypic fusion of ISGs, and (4) remodeling of the ISG membrane and contents (Tooze et al. 2001).
Chromogranin A (CgA) is a major soluble protein of the secretory vesicles of NE cells that interacts with several other integral SG membrane proteins at pH 5.5 and dissociates from them at pH 7.5 (Yoo 1993,1994). Expression of chromogranin/secretogranin proteins is widespread in NE cells (Fischer-Colbrie et al. 1985; Simon and Aunis 1989). Among the SG-related proteins, CgA is regarded as a major marker of the NE system (Linnoila et al. 1988; Lloyd et al. 1988,1989; Eriksson et al. 1990). Chromogranins (Cgs) play not only granulogenic roles but also induce SG formation even in non-NE cells (Kim et al. 2001; Rustom et al. 2002; Huh et al. 2003) or inhibit cell growth of non-NE cells (folliculostellate cells of the pituitary gland) (Stilling et al. 2005). CgA might serve as a model for studies of proteins involved in the regulated pathway of secretion. Human CgA has a molecular mass of 49 kDa and comprises 439 amino acids. Its mRNA encodes a protein of 457 amino acids, the first 18 of which constitute the signal sequence. Overexpression of CgA induces dense-core granules that are immunoreactive for CgA in non-endocrine fibroblast CV-1 cells (Kim et al. 2001).
Green fluorescent protein (GFP) has been widely applied as a tag to localize protein generated by gene transfection. It can monitor the transfection of cells as a reporter for promoter activity or localize fusion proteins in the cytosol. Fusing a RSP to a GFP variant to form a chimera should allow the study of granulogenesis in real time, i.e., granule maturation and speed of granular transport (Kaether and Gerdes 1995,1997; Burke et al. 1997; Lang et al. 1997).
This study determines whether an enhanced GFP (EGFP)-tagged CgA gene construct could serve as a marker protein to follow the synthesis of CgA in non-NE cells via granulogenesis. We focused on granulogenesis induced in non-NE cells after transfection with a CgA-EGFP construct.
|
Materials and Methods |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Cells
Monkey COS-7 cells were obtained from the RIKEN Cell Bank (RCB0539; Ibaraki, Japan) and maintained in DMEM (Invitrogen; Carlsbad, CA) supplemented with 10% FBS (Invitrogen) and 100 U/ml penicillin–streptomycin (Invitrogen). Cells were incubated at 37C in a humidified atmosphere (5% CO2/95% air).
Transfection of Expression Vector pCMV-CgA-EGFP
The expression vector pCMV-CgA-EGFP for chimeric protein CgA-EGFP was designed as previously described (Taupenot et al. 2002). Briefly, full-length DNA of human CgA (Helman et al. 1988) including the 18 amino acid signal peptide (MRSAAVLALLLCAGQVTA) was cloned into the pCMV expression vector (Taupenot et al. 2002). Amplified full-length human CgA (SgP-CgA) was purified and subcloned into the XhoI/KpnI site of the pCMV-EGFP (N2) vector (Clontech Laboratories; Mountain View, CA) (Figure 1
). The predicted molecular mass for SgP-CgA-EGFP was 75.8 kDa as calculated molecular mass and 105 kDa as apparent molecular mass by SDS-PAGE.
|
COS-7 cells in Permanox chamber slides (Nalge Nunc International; Rochester, NY) or glass-bottomed culture dishes (FastGeneTM; NIPPON Genetics Co. Ltd., Tokyo, Japan) were transiently transfected with DNA (pCMV-CgA-EGFP or pCMV-EGFP) using FuGENE HD (Roche Applied Science; Indianapolis, IN) according to the manufacturer's instructions. Cells were then harvested 48 hr later and fixed.
Immunoblot Analysis
Extracted cellular proteins were resolved by SDS-PAGE on 10% polyacrylamide gels and transferred to nitrocellulose membranes (Schleicher and Schuell BioScience; Keene, NH). Nonspecific binding was blocked by incubation for 1 hr in PBS buffer containing 5% non-fat dry milk and 2% non-immune sheep serum. Membranes were then reacted with monoclonal anti-CgA, LK2H10 (Immunon; Pittsburgh, PA), or monoclonal anti-GFP, 11E5 (Molecular Probes, Invitrogen) for 1 hr and washed for 15 min with 0.05% Tween 20 in PBS. Blots were subsequently incubated for 1 hr with horseradish peroxidase-conjugated secondary antibodies (GE Healthcare UK Ltd.; Buckinghamshire, UK) in blocking buffer. Immunoreactive proteins were visualized using the ECL Plus Western Blotting Detection System as chemiluminescence (GE Healthcare U.K. Ltd.).
Electron and Immunoelectron Microscopy
Cells cultured in plastic chamber slides (Lab-Tek; Nalge Nunc International) were fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4, at room temperature for 30 min, washed with buffer, and immersed in 0.1 M phosphate buffer containing 1% osmium tetroxide for 30 min. Slides were washed with buffer, dehydrated in ethanol, and embedded in epoxy resin. Ultrathin sections were attached to nickel grids that were counterstained with uranyl acetate and lead citrate. After confirming SG by electron microscopy (EM), the ultrathin sections on nickel grids were etched by incubating in 10% H2O2 for 10 min, washed with three successive droplets of 1% BSA/PBS buffer, and then incubated overnight at 4C in a humidified chamber with droplets of anti-CgA antibody (diluted 1:50, LK2H10; Immunon). After washing as described above, grids were incubated for 1 hr at room temperature with droplets of BSA/PBS buffer containing secondary antibody labeled with gold particles (5-nm average diameter). The grids were washed once with BSA/PBS and three times with distilled water and finally stained with uranyl acetate and lead citrate.
Chimeric Photoprotein Fluorescence
COS-7 cells cultured and in glass-bottomed culture dishes (FastGeneTM; NIPPON Genetics) were transfected for 48 hr with expression plasmids encoding the indicated EGFP fusion protein, fixed in 4% paraformaldehyde, and examined by confocal laser scanning microscopy (CLSM) (LSM510META; Carl Zeiss, Jena, Germany).
Immunocytochemistry
For immunocytochemistry, COS-7 cells cultured on glass-bottomed culture dishes were transfected and fixed in 4% paraformaldehyde. Cells were permeabilized with 0.4% Triton X-100 (Sigma; St Louis, MO), and nonspecific binding was blocked with 1% normal horse serum in PBS for 30 min at room temperature. A monoclonal antibody to detect human CgA (dilution 1:50, LK2H10; Immunon) and a polyclonal antibody to detect lysosomal marker, LAMP-1 (dilution 1:200, H-228; Santa Cruz Biotechnology, Santa Cruz, CA) were applied to the cells. After a PBS wash, quantum dot (Qd) (525 nm)-labeled second antibody for CgA (dilution 1:250; Invitrogen) and Qd-labeled (605 nm) second antibody (dilution 1:250; Invitrogen) for LAMP-1 were added to the cells. Slides were mounted to improve the signal-to-background ratio before visualization by an incubation for 20–30 min with ToTo-3 (dimeric cyanine nucleic acid dyes; Invitrogen) in 1,4-diazabicyclo[2.2.2]octane (DABCO; Sigma). ToTo-3 dye was diluted to 2.4 nM in PBS (200 µL) and directly applied to the slides. The slides were stored protected from light at 4C.
Spectral Analysis
Specimens were examined by computer-assisted image spectrum analysis using the LSM-510 META (Carl Zeiss) in lambda stack mode. The META analysis was arranged to ensure optimal specimen illumination and efficient collection of emitted light, which allows digital separation of the component dyes. First, a lambda stack was acquired to determine the spectral signature of each specimen by recording the spectral distribution of fluorescence emissions in 10.7-nm increments. Because spectrally resolved images are simultaneously recorded, this step is completed very quickly, which is optimal for delicate specimens, and fast dynamic processes can be reliably captured. EGFP, Qd525, and Qd605 were excited at 488 nm using an argon laser, and ToTo-3 was excited using a 633 HeNe laser.
|
Results |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Protein Products of CgA-EGFP in Transfected COS-7 Cells Detected by Immunoblotting
Cellular expression of the chimeric protein CgA-EGFP was confirmed by immunoblotting lysates from transfected COS-7 cells with antibodies to human CgA and GFP. Figure 2 shows products of
105 kDa on SDS-PAGE that are consistent with the predicted mass of the full-length human CgA-GFP chimera (75 kDa for human CgA plus 27 kDa for GFP) (Taupenot et al. 2002). CgA from humans and other species has abnormal SDS-PAGE mobility, and its apparent molecular mass (70–75 kDa) is substantially higher than the predicted value of 50 kDa (Helman et al. 1988; Taupenot et al. 1995), which is a result of the highly anionic pI of CgA. A GFP-immunoreactive band was detected in extracts of pCMV-EGFP transfected COS-7 cells at 25 kDa (not shown). Immunoreactivity to CgA-EGFP was absent in pCMV-EGFP transfected and non-transfected cells.
|
Distribution of Chimeric CgA-EGFP Protein by CLSM
We designed an expression plasmid encoding the enhanced fluorescence variant of wild-type GFP fused at the N-terminus of EGFP, to the C-terminus of full-length human CgA (pCMV-CgA-EGFP; Figure 1). The single, red-shifted excitation peak of EGFP (mutations Ser65 to Thr65 and Phe64 to Leu64) fluoresces
35-fold more intensely than wild-type GFP when excited at 488 nm. Intracellular distribution of CgA-EGFP chimeric protein was assessed by CLSM in COS-7 cells fixed with paraformaldehyde (Figure 3
). Non-fused EGFP was diffusely distributed in the cytosol of pCMV-EGFP transfected COS-7 cells (data not shown).
|
Signals of chimeric CgA-EGFP protein were diffuse and/or accumulating and aggregating in the cytoplasm and perinuclear area, consistent with the Golgi field (Figure 3A, green signals). Fluorescence corresponding to EGFP or chimeric CgA-EGFP was not detected in non-transfected cells (data not shown). We further investigated the intracellular localization of CgA-EGFP by immunocytochemistry using a monoclonal antibody (LK2H10) against human CgA (Figure 3B, red signals). Figure 3B shows a non-uniform punctate distribution of anti-CgA-Qd525- immunocytochemically stained signals (red) throughout but more at the peripheral region of the cytoplasm. The CgA-Qd525 signal was excluded from the nucleus. Green signals of chimeric CgA-EGFP protein and red CgA-Qd525 signals that colocalized in a granular fashion merged into yellow (Figure 3D).
With CLSM we could clearly demonstrate that the signals of CgA-EGFP (Figure 4A , green in color) and LAMP-1 (Figure 4B, red in color) are mainly localized in different granules (Figure 4D).
|
SG Formation Identified by EM
Despite the absence of endogenous SGs in non-transfected COS-7 cells (Figure 5A ), COS-7 cells transfected with pCMV-CgA-EGFP contained granule-like structures (Figure 5B). These structures varied in size from
150 to 250 nm, which was larger than the dense-core SGs in PC12 cells (Taupenot et al. 2003) or in non-NE cells (Kim et al. 2001). Granules were composed of an outer limiting membrane with core structures that were interpreted as SGs. In contrast, COS-7 cells transfected with pCMV-EGFP did not produce granular structures (data not shown). Immuno-EM analysis of human CgA in COS-7 cells transfected with pCMV-CgA-EGFP revealed the presence of several dense-core granules that were specifically stained for human CgA (LK2H10), indicating that human CgA was packaged into membrane-bound structures (Figure 5B, inset). Human CgA labeled with 5-nm gold particles was absent in mitochondria, underscoring the presence of human CgA formed de novo in the dense core granules of the cells.
|
Distinct Distribution of CgA and EGFP Determined by CLSM Spectrum Analysis
Three-dimensional confocal META analyses revealed individual signals from CgA-EGFP, EGFP, and CgA-QD525 in COS-7 cells transfected with pCMV-CgA-EGFP as an unmixed image. Figure 6 shows individual signals of CgA-EGFP, EGFP, and CgA-QD525 discriminated by META spectral analysis. Emission spectra of the reference signals from chimeric protein CgA-EGFP (Figure 6A), EGFP (Figure 6B), CgA-Qd525 (Figure 6C), and ToTo-3 counterstain (Figure 6J) were defined, and all fluorescence emission spectra were merged in Figure 6K. The input images were then calculated and individual signals were separated in the liner-unmixing mode (Figures 6D–6G; CgA-EGFP chimeric protein signal, green; EGFP, yellow; CgA-Qd525, red; ToTo-3 nuclear, blue).
|
These results show that chimeric CgA-EGFP protein, unfused EGFP, and CgA immunoreactivity emitted distinct signals that were differently distributed for a short period. Accumulated and aggregated CgA-EGFP fluorescence signals were detected in the cytoplasm and perinuclear Golgi field (Figure 6D). Granule-like signals of EGFP were distributed mainly in the cytoplasm (Figure 6E). Fine, dotted CgA signals were mainly localized in the peripheral region excluding the Golgi field (Figure 6F). Nuclei were counterstained with ToTo-3 (Figure 6G). CgA-EGFP chimeric protein signals (green) and EGFP signals (yellow) were differently distributed. EGFP signals were mainly in the perinuclear area, whereas speckled CgA-EGFP signals were aggregated in the periphery of the cytoplasm.
|
Discussion |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
This is the first report to demonstrate granular structure produced by transfecting the EGFP-tagged human CgA gene into non-NE COS-7 cells. The role of the granin family in granulogenesis in NE and non-NE cells has been demonstrated by transfection with the CgA and CgB genes (Kim et al. 2001
; Huh et al. 2003). To understand the functional role of granins and intracytoplasmic localization, GFP-tagged Cgs can be powerful tools. For example, GFP-tagged human CgB has been transfected into non-NE cells, which has led to granule formation (Kaether and Gerdes 1995; Wacker et al. 1997; Tvarusko et al. 1999). We therefore investigated the role of CgA in the process of granulogenesis in vitro. Another striking finding was that CgA and EGFP are not always identically distributed in the cytoplasm. In cells transfected with EGFP-tagged CgA, the EGFP signal indicates CgA itself, so CgA localization has not been further examined. In the present study we investigated the localization of EGFP and CgA using an additional cytochemical technique and found that the CgA distribution did not always coincide with the EGFP signal. We found that fluorescence signals for chimeric CgA-EGFP or EGFP protein were distributed in the cytoplasm and mainly in the Golgi fields. In contrast, CgA-Qd525 signals were immunocytochemically localized mainly to the periphery of the cytoplasm (Figure 3). One explanation for this is that the fusion protein could be processed in the TGN, and only CgA lacking EGFP was packed in the mature granules.
The process of granule formation has been investigated in detail by EM. Morphology and final size of granules are diverse and depend on the cell type and granule contents. MSGs in PC12 cells are 120 nm, whereas insulin granules in ß cells are 200 nm in diameter. The biogenesis of SGs has been thoroughly investigated in NE cells. In PC12 cells, ISGs bud from the Golgi apparatus as small granules. The diameter of ISGs in NE cells is 80 nm, which is the same as that of coated vesicles (Tooze et al. 1991), suggesting that coat proteins are involved in ISG budding from the TGN. Small ISGs of a similar size and character then undergo homotypic fusion (Urbe et al. 1998), which is considered necessary for SG maturation in NE cells. The present study found that SGs were between 150 and 250 nm in diameter and were consistent with the size of mature granules.
Core density of the granular structures also indicates SG maturity. Previous EM studies have shown that granules have low electron density in NE, endocrine, and exocrine cells (Arvan and Castle 1992; Tooze et al. 2001). Such low-density organelles are thought to be ISGs undergoing maturation. SGs identified in the present study were not dense compared with those of typical MSGs. We speculated that COS-7 cells transfected with CgA-EGFP cannot produce compounds such as peptide hormones in SGs; thus, SGs remained immature.
The role of CgA has been under discussion. Kim et al. (2001) reported the role of CgA as a key protein for on/off switch regulating granulogenesis by reduction and overexpression analyses of CgA. Day and Gorr (2003), however, pointed out the facts that SGs could exist in the absence of CgA and that CgA could be synthesized in the absence of SGs. They proposed the role of CgA on the condensation of SG cargo rather than a mastergene or universal on/off switch for granulogenesis. They also detected that the granular structures shown as SGs by Kim et al. (2001) were distinct from SGs, lysosomes, or endosomes. Morphological differentiation between SGs and CgA-containing lysosomes is critical in the present study. Although immuno-EM study for lysosomal protein could not be performed, we demonstrated that CgA and LAMP-1 were detected in different granules with a few exceptional colocalizations. There are a few granules containing CgA and lysosomes, but larger numbers of CgA were contained in non-lysosomal vesicles. Thus, we consider that this evidence sufficiently excludes the possibility of colocalization of CgA in the lysosome. To investigate whether or not CgA is a master gene for granulogenesis, transcription of downstream genes including secretory proteins or functional analyses is to be further examined. Nonetheless, results of the present study support the hypothesis that CgA acts to assemble or aggregate the CgA-contributing granular structure formation (Day and Gorr 2003).
In conclusion, EGFP-tagged CgA is a powerful tool to investigate how CgA contributes to granulogenesis.
|
Footnotes |
|---|
Received for publication October 4, 2006; accepted December 22, 2006
|
Literature Cited |
|---|
|
TopSummaryIntroductionMaterials and MethodsResultsDiscussionLiterature Cited |
|---|
Arvan P, Castle D (1992) Protein sorting and secretion granule formation in regulated secretory cells. Trends Cell Biol 2:327–331[CrossRef][Medline]
Arvan P, Castle D (1998) Sorting and storage during secretory granule biogenesis: looking backward and looking forward. Biochem J 332:593–610
Burke NV, Han W, Li D, Takimoto K, Watkins SC, Levitan ES (1997) Neuronal peptide release is limited by secretory granule mobility. Neuron 19:1095–1102[CrossRef][Medline]
Day R, Gorr SU (2003) Secretory granule biogenesis and chromogranin A: master gene, on/off switch or assembly factor? Trends Endocrinol Metab 14:10–13[CrossRef][Medline]
Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C, Wilander E (1990) A polyclonal antiserum against chromogranin A and B—a new sensitive marker for neuroendocrine tumours. Acta Endocrinol (Copenh) 122:145–155
Fischer-Colbrie R, Lassmann H, Hagn C, Winkler H (1985) Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissues. Neuroscience 16:547–555[CrossRef][Medline]
Helman LJ, Ahn TG, Levine MA, Allison A, Cohen PS, Cooper MJ, Cohn DV, et al. (1988) Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA. J Biol Chem 263:11559–11563
Huh YH, Jeon SH, Yoo SH (2003) Chromogranin B-induced secretory granule biogenesis: comparison with the similar role of chromogranin A. J Biol Chem 278:40581–40589
Kaether C, Gerdes HH (1995) Visualization of protein transport along the secretory pathway using green fluorescent protein. FEBS Lett 369:267–271[CrossRef][Medline]
Kaether C, Salm T, Glombik M, Almers W, Gerdes HH (1997) Targeting of green fluorescent protein to neuroendocrine secretory granules: a new tool for real time studies of regulated protein secretion. Eur J Cell Biol 74:133–142[Medline]
Kim T, Tao-Cheng JH, Eiden LE, Loh YP (2001) Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell 106:499–509[CrossRef][Medline]
Lang T, Wacker I, Steyer J, Kaether C, Wunderlich I, Soldati T, Gerdes HH, et al. (1997) Ca2+-triggered peptide secretion in single cells imaged with green fluorescent protein and evanescent-wave microscopy. Neuron 18:857–863[CrossRef][Medline]
Linnoila RI, Mulshine JL, Steinberg SM, Funa K, Matthews MJ, Cotelingam JD, Gazdar AF (1988) Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol 90:641–652[Medline]
Lloyd RV, Cano M, Rosa P, Hille A, Huttner WB (1988) Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Am J Pathol 130:296–304[Abstract]
Lloyd RV, Iacangelo A, Eiden LE, Cano M, Jin L, Grimes M (1989) Chromogranin A and B messenger ribonucleic acids in pituitary and other normal and neoplastic human endocrine tissues. Lab Invest 60:548–556[Medline]
Rustom A, Bajohrs M, Kaether C, Keller P, Toomre D, Corbeil D, Gerdes HH (2002) Selective delivery of secretory cargo in Golgi-derived carriers of nonepithelial cells. Traffic 3:279–288[CrossRef][Medline]
Simon JP, Aunis D (1989) Biochemistry of the chromogranin A protein family. Biochem J 262:1–13[Medline]
Stilling GA, Bayliss JM, Jin L, Zhang H, Lloyd RV (2005) Chromogranin A transcription and gene expression in folliculostellate (TtT/GF) cells inhibit cell growth. Endocr Pathol 16:173–186[CrossRef][Medline]
Taupenot L, Harper KL, Mahapatra NR, Parmer RJ, Mahata SK, O'Connor DT (2002) Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. J Cell Sci 115:4827–4841
Taupenot L, Harper KL, O'Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348:1134–1149
Taupenot L, Remacle JE, Helle KB, Aunis D, Bader MF (1995) Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides. Regul Pept 56:71–88[CrossRef][Medline]
Tooze SA (1998) Biogenesis of secretory granules in the trans-Golgi network of neuroendocrine and endocrine cells. Biochim Biophys Acta 1404:231–244[Medline]
Tooze SA, Flatmark T, Tooze J, Huttner WB (1991) Characterization of the immature secretory granule, an intermediate in granule biogenesis. J Cell Biol 115:1491–1503
Tooze SA, Martens GJ, Huttner WB (2001) Secretory granule biogenesis: rafting to the SNARE. Trends Cell Biol 11:116–122[CrossRef][Medline]
Tvarusko W, Bentele M, Misteli T, Rudolf R, Kaether C, Spector DL, Gerdes HH, et al. (1999) Time-resolved analysis and visualization of dynamic processes in living cells. Proc Natl Acad Sci USA 96:7950–7955
Urbe S, Page LJ, Tooze SA (1998) Homotypic fusion of immature secretory granules during maturation in a cell-free assay. J Cell Biol 143:1831–1844
Wacker I, Kaether C, Kromer A, Migala A, Almers W, Gerdes HH (1997) Microtubule-dependent transport of secretory vesicles visualized in real time with a GFP-tagged secretory protein. J Cell Sci 110:1453–1463[Abstract]
Winkler H, Fischer-Colbrie R (1992) The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49:497–528[CrossRef][Medline]
Yoo SH (1993) pH-dependent association of chromogranin A with secretory vesicle membrane and a putative membrane binding region of chromogranin A. Biochemistry 32:8213–8219[CrossRef][Medline]
Yoo SH (1994) pH-dependent interaction of chromogranin A with integral membrane proteins of secretory vesicle including 260-kDa protein reactive to inositol 1,4,5-triphosphate receptor antibody. J Biol Chem 269:12001–12006
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |